Chemical Structure : CFT8634
CAS No.: 2704617-96-7
Catalog No.: PC-73316Not For Human Use, Lab Use Only.
CFT-8634 (CFT8634) is a potent, selective, orally bioavailable BRD9 PROTAC degrader with DC50 of 3 nM, high selectivity over BRD4 abd BRD7.
| Packing | Price | Stock | Quantity |
|---|---|---|---|
| 1 mg | $198 | In stock | |
| 2 mg | $328 | In stock | |
| 5 mg | $528 | In stock | |
| 10 mg | Get quote | ||
| 25 mg | Get quote |
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
CFT-8634 (CFT8634) is a potent, selective, orally bioavailable BRD9 PROTAC degrader with DC50 of 3 nM, high selectivity over BRD4 abd BRD7.
Unlike BRD9 inhibition, BRD9 degradation is efficacious in preclinical models of synovial sarcoma and CFT8634 is ongoing for the treatment of SMARCB1-perturbed cancers.
| M.Wt | 710.799 | |
| Formula | C37H45F3N6O5 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
(3S)-3-[[4-[4-[(4S)-1-[[4-(1,6-Dihydro-1,4,5-trimethyl-6-oxo-3-pyridinyl)-2,6-dimethoxyphenyl]methyl]-3,3-difluoro-4-piperidinyl]-1-piperazinyl]-3-fluorophenyl]amino]-2,6-piperidinedione |
|
1. Patent WO2021178920A1.
2.Jackson, et al. Cancer Research 82.12_Supplement (2022): ND09-ND09.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright